help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enomoto, T.
Right arrow Articles by Imura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enomoto, T.
Right arrow Articles by Imura, H.

Endocrinology, Vol 127, 2322-2327, Copyright © 1990 by Endocrine Society


ARTICLES

Prolonged effects of recombinant human interleukin-1 alpha on mouse thyroid function

T Enomoto, H Sugawa, S Kosugi, D Inoue, T Mori and H Imura
Second Division of Internal Medicine, Clinical Molecular Biology, Kyoto University School of Medicine, Japan.

Rapid and prolonged effects of recombinant human interleukin-1 alpha (IL-1 alpha) on mouse thyroid were studied. After daily administration of 15 micrograms or 1 microgram IL-1 for 7 consecutive days, serum T4 concentrations rapidly fell to undetectable levels but returned to near control level after the cessation of IL-1. On the 31st day, 3 weeks after the drug cessation, a significant depression of serum T4 was observed again. In addition, the IL-1-treated mouse thyroid showed an in vitro unresponsiveness to TSH, with an increase of pituitary TSH (2.24-fold by 15 micrograms IL-1). To understand underlying mechanisms further, serial observations were performed. Thyroidal T4 contents increased initially, decreased to a low level at day 14, and returned to approximately the control level. IL-1 administration induced an increase in the basal thyroidal cAMP level for a prolonged period. Its response to TSH showed a gradual decline to a level approximately 30% of the control by the 31st day. Pituitary TSH contents on the 22nd and 31st days showed significant elevations. Slight decreases in thyroidal TSH binding and T4 contents also were seen concomitantly. These studies indicate that an administration of a large dose of IL-1 results in a dramatic decrease in serum T4 primarily through the inhibition of T4 release from the thyroid. The results also indicate the induction of a prolonged hypothyroid state due to the unresponsiveness to TSH via a postreceptor mechanism.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. D. Mainwaring, J. J. Lamberti, and T. E. Hugli
Complement Activation and Cytokine Generation After Modified Fontan Procedure
Ann. Thorac. Surg., June 1, 1998; 65(6): 1715 - 1720.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Nilsson, J. Husmark, U. Björkman, and L. E. Ericson
Cytokines and Thyroid Epithelial Integrity: Interleukin-1{alpha} Induces Dissociation of the Junctional Complex and Paracellular Leakage in Filter-Cultured Human Thyrocytes
J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 945 - 952.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Ramirez, L. E. Braverman, B. White, and C. H. Emerson
Recombinant Human Thyrotropin Is a Potent Stimulator of Thyroid Function in Normal Subjects
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2836 - 2839.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society